Key result
In-hospital mortality following PCI for ACS increased from 1.7% in 2006 to 3.1% in 2021, with ACS subtypes and medical history being the strongest contributors to this difference.
Why the study?
Data are limited regarding the drivers of changes in mortality over time following PCI for ACS.
Observational (n=743,149)
Yes
Answers are grounded in this paper and cite their sources.
The observed increase in short-term mortality following PCI for ACS between 2006 and 2021 in England and Wales is largely driven by changes in patient factors, medical history, and a shift towards STEMI presentations.
Abstract Background There is limited data around drivers of changes in mortality over time. We aimed to examine the temporal changes in mortality and understand its determinants over time. Methods 743,149 PCI procedures for patients from the British Cardiovascular Intervention Society (BCIS) database who were aged between 18 and 100 years and underwent Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome (ACS) in England and Wales between 2006 and 2021 were included. We decomposed the contributing factors to the difference in the observed mortality proportions between 2006 and 2021 using Fairlie decomposition method. Multiple imputation was used to address missing data. Results Overall, there was an increase in the mortality proportion over time, from 1.7% (95% CI: 1.5% to 1.9%) in 2006 to 3.1% (95% CI: 3.0% to 3.2%) in 2021. 61.2% of this difference was explained by the variables included in the model. ACS subtypes (percentage contribution: 14.67%; 95% CI: 5.76% to 23.59%) and medical history (percentage contribution: 13.50%; 95% CI: 4.33% to 22.67%) were the strongest contributors to the difference in the observed mortality proportions between 2006 and 2021. Also, there were different drivers to mortality changes between different time periods. Specifically, ACS subtypes and severity of presentation were amongst the strongest contributors between 2006 and 2012 while access site and demographics were the strongest contributors between 2012 and 2021. Conclusions Patient factors and the move towards ST-elevated myocardial infarction (STEMI) PCI have driven the short-term mortality changes following PCI for ACS the most.
No takes yet. Share an insight, caveat, or question.
Ayayo et al. (2024) conducted an observational in Acute Coronary Syndrome (ACS) (n=743,149). Percutaneous Coronary Intervention (PCI) vs. Temporal comparison (2006 vs 2021) was evaluated on In-hospital mortality proportion. In-hospital mortality following PCI for ACS increased from 1.7% in 2006 to 3.1% in 2021, with ACS subtypes and medical history being the strongest contributors to this difference.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: